Current Molecular Medicine (CMM)

Current Molecular Medicine is a respected, peer‑reviewed scientific journal dedicated to publishing research and reviews that advance understanding of molecular processes underlying human health and disease. It serves as an interdisciplinary platform for researchers and clinicians working at the intersection of molecular biology, biochemistry, and medicine, focusing on the fundamental mechanisms of disease pathogenesis and the translation of molecular insights into diagnostic and therapeutic strategies. The journal publishes a wide range of article types, including original research reports, comprehensive review articles, mini‑reviews, short communications, letters, and drug clinical trial studies. Its coverage spans topics such as molecular signaling pathways, gene expression and regulation, biomarkers and molecular diagnostics, target identification, therapeutic development, and mechanistic studies that bridge laboratory findings with clinical applications. By presenting both basic and applied research, Current Molecular Medicine supports the scientific community in deciphering complex molecular interactions that drive disease and in fostering innovative approaches for prevention, diagnosis, and personalized treatment. Its interdisciplinary scope makes it valuable to molecular biologists, clinicians, pharmacologists, and translational scientists seeking to push the boundaries of medical science.

Current Molecular Medicine (CMM) is :-

• International, Peer-Reviewed, Open Access, Refereed, Molecular Medicine, Biochemistry & Molecular Biology, Life Sciences, Medicine (Research & Experimental), Molecular mechanisms of disease, General Medicine , Online or Print , Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 1566-5240, E-ISSN: 1875-5666, Established: 2001, Impact Factor: 2.5
• Does Not Provide Crossref DOI

• Not indexed in Scopus, WoS, DOAJ, PubMed, UGC CARE